News and actuality

Current press releases, talks and reports


Cologne, November 17, 2015 – NEO New Oncology AG announced today the commercial launch of “NEOliquid”, a non-invasive cancer diagnostics test. NEOliquid is uniquely able to detect all therapeutically relevant point mutations, small insertions and deletions, translocations and...

Read more

Cologne, November 5 2015 – NEO New Oncology AG announced today the launch of its prospective registry “NEOlung”. In this study, approximately 1,500 patients with advanced or metastatic lung cancer will gain direct and timely access to comprehensive molecular diagnostics and...

Read more

Oldenburg / Hamburg / Cologne, November 4, 2015 – The Pius Hospital Oldenburg, the Institute of Hematopathology Hamburg and NEO New Oncology AG announced today the formation of NOWEL, the North-East-West Lung Network (Nord-Ost-West-Lunge, NOWEL, www.nowel.org). The objective of...

Read more

Researchers from the University of Cologne and NEO New Oncology AG publish new findings on the importance of thorough molecular diagnosis in cancer

Read more

Cologne, October 9, 2015 – NEO New Oncology AG, a Cologne based cancer diagnostics company, today announced the closing of a financing round with a total investment of app. EUR 5 Million.

“I am pleased by the strong interest that NEO New Oncology AG has received from the...

Read more

Kontakt

Telephone

Office: +49.221.888.23 80

Address

NEO New Oncology GmbH
Gottfried-Hagen-Str. 20
51105 Cologne
Germany

ImprintPrivacy policy

Newoncology.com uses cookies to make the website more user-friendly. By continuing to use the website, you agree to the use of cookies. If you do not agree to the storage of cookies, you will find further information HERE.

ok